Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00478478|
Recruitment Status : Completed
First Posted : May 24, 2007
Last Update Posted : November 10, 2014
Post-Market Registry on Use of Merci Retrieval System. Primary data to be collected will include:
- Post-procedure revascularization success
- 90-day mRS 0-2
- 90-day mortality
|Condition or disease||Intervention/treatment|
|Ischemic Stroke||Procedure: Mechanical Thrombectomy|
The Merci Registry is a prospective multicenter registry with up to 3000 patients enrolled at a maximum of 100 sites.
The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.
|Study Type :||Observational|
|Actual Enrollment :||1000 participants|
|Official Title:||Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke|
|Study Start Date :||June 2007|
|Actual Primary Completion Date :||May 2010|
|Actual Study Completion Date :||September 2010|
Acute Ischemic Stroke patients
Patients presenting with signs and symptoms consistent with a diagnosis of Acute Ischemic Stroke, who are treated with the Merci Retrieval System during a Mechanical Thrombectomy procedure.
Procedure: Mechanical Thrombectomy
Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.
Other Name: Merci Retrieval System
- Post-procedure revascularization success [ Time Frame: post-procedure ]
- NIHSS change from baseline to 24-hours [ Time Frame: 24-hour ]
- 90-day mRS outcomes [ Time Frame: 90-day ]
- 90-day mortality [ Time Frame: 90-day ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00478478
|United States, Missouri|
|St. Luke's Brain and Stroke Institute|
|Kansas City, Missouri, United States, 64111|
|Principal Investigator:||Wade S Smith, MD, PhD||University of California at San Francisco, SF, CA|
|Principal Investigator:||Marilyn M Rymer, MD||MABSI St. Luke's, Kansas City, MO|